Editorial Comment to Tri‐modality therapy with i‐125 brachytherapy, external beam radiation therapy, and short‐term hormone therapy for high‐risk prostate cancer after holmium lase... by Ikko Tomisaki

Get full text

Editorial Comment to Pembrolizumab‐induced myasthenia gravis with myositis and presumable myocarditis in a patient with bladder cancer by Ikko Tomisaki

Get full text

Editorial Comment to A conservative treatment for eosinophilic cystitis by Ikko Tomisaki

Get full text

Small cell carcinoma of the kidney treated with immune checkpoint inhibitor/tyrosine kinase inhibitor by Mirii Harada, Ikko Tomisaki, Shohei Shimajiri, Keisuke Kuretake, Kenichi Harada, Naohiro Fujimoto

Get full text

Primary retroperitoneal mucinous cystadenocarcinoma with transition from the mesothelium by Ikko Tomisaki, Atsuji Matsuyama, Mao Jotatsu, Sohei Yamamura, Rei Onishi, Naohiro Fujimoto

Get full text

Premature Mortality Due to Malignancies of the Kidney and Bladder in Japan, 1980–2010 by Truong-Minh Pham, Tatsuhiko Kubo, Yoshihisa Fujino, Naohiro Fujimoto, Ikko Tomisaki, Akinori Minato, Shinya Matsuda

Get full text

Prognostic Impact of Histologic Subtype and Divergent Differentiation in Patients with Metastatic Urothelial Carcinoma Treated with Enfortumab Vedotin: A Multicenter Retrospective... by Akinori Minato, Nobuki Furubayashi, Yujiro Nagata, Toshihisa Tomoda, Hiroyuki Masaoka, Yoohyun Song, Yoshifumi Hori, Keijiro Kiyoshima, Takahito Negishi, Kentaro Kuroiwa, Narihito Seki, Ikko Tomisaki, Kenichi Harada, Motonobu Nakamura, Naohiro Fujimoto

Get full text